A hospital biostatistics committee is reviewing the diagnostic protocols for a novel continuous quantitative serum biomarker used to detect severe sepsis. Depending on the primary clinical objective and the target population, the decision thresholds (cutoffs) and pretest probabilities may vary. Match each proposed clinical or protocol adjustment on the left with its theoretical impact on the test's statistical performance metrics on the right.
- Increasing the numeric cutoff threshold for a positive test to prioritize the avoidance of unnecessary broad-spectrum antibiotic administration.Decreases the type I error rate and false discovery rate; increases the type II error rate.
- Decreasing the numeric cutoff threshold for a positive test to minimize the risk of missing early-stage septic shock.Decreases the type II error rate and false omission rate; increases the type I error rate.
- Implementing the assay exclusively in the intensive care unit, where the baseline incidence of severe sepsis is significantly elevated.Decreases the false discovery rate and increases the false omission rate; likelihood ratios remain unaffected.
- Expanding the biomarker screening to all walk-in urgent care patients, where the baseline incidence of severe sepsis is exceedingly rare.Increases the false discovery rate and decreases the false omission rate; likelihood ratios remain unaffected.
Cevap
Adjustments to cutoff thresholds alter intrinsic characteristics (Type I/II error rates) and predictive values, while changes to population prevalence alter only predictive values (FDR/FOR) without affecting intrinsic characteristics or likelihood ratios.
Matching the clinical adjustments to their statistical outcomes relies on separating intrinsic test property alterations from prevalence-driven predictive value shifts. Changing the cutoff threshold directly trades Type I errors for Type II errors (altering Sensitivity, Specificity, and Likelihood Ratios), while changing the tested population alters only the baseline prevalence, shifting the False Discovery Rate (1 - PPV) and False Omission Rate (1 - NPV) without affecting the Likelihood Ratios.
Adım Adım Çözüm
Anahtar Kavram
The relationship between diagnostic thresholds, disease prevalence, and derivative statistical metrics including Type I/II errors, false discovery/omission rates, and likelihood ratios.
Alternatif Yöntem
Drawing out a 2x2 contingency table for each scenario and placing arrows indicating which cells increase or decrease can visually confirm these abstract mathematical relationships.
Tahmini Süre:2m 30s